Advertisement

Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 914–915 | Cite as

ASO Author Reflections: The Future of Isolated Limb Perfusion

  • Dimitrios Katsarelias
  • Roger Olofsson BaggeEmail author
ASO Author Reflections
  • 39 Downloads

Notes

Disclosure

Dimitrios Katsarelias and Roger Olofsson Bagge have no conflicts of interest to disclose.

References

  1. 1.
    Moreno-Ramirez D, et al., Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety. Oncologist. 2010;15(4):416–27.CrossRefPubMedCentralGoogle Scholar
  2. 2.
    Testori A, Ribero S, Bataille V. Diagnosis and treatment of in-transit melanoma metastases. Eur J Surg Oncol. 2017;43(3):544–60.CrossRefGoogle Scholar
  3. 3.
    Wolchok JD, et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2017;377(14):1345–56.CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Katsarelias D, et al. The Effect of temperature and perfusion time on response, toxicity, and survival in patients with in-transit melanoma metastases treated with isolated limb perfusion. Ann Surg Oncol. 2018;25:1836–42.CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Ariyan CE, et al. Robust antitumor responses result from local chemotherapy and CTLA-4 blockade. Cancer Immunol Res. 2018;6(2):189–200.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of Surgery, Institute of Clinical SciencesSahlgrenska Academy at the University of Gothenburg, Sahlgrenska University HospitalGothenburgSweden

Personalised recommendations